Cargando…
Correction: Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472106/ https://www.ncbi.nlm.nih.gov/pubmed/36096535 http://dx.doi.org/10.1136/jitc-2022-004693corr1 |
Ejemplares similares
-
Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
por: Maddineni, Sainiteesh, et al.
Publicado: (2022) -
iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors
por: Bogomiakova, Margarita E., et al.
Publicado: (2023) -
Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity
por: Flahou, Charlotte, et al.
Publicado: (2021) -
Possible NK cell-mediated immune responses against iPSC-derived cells in allogeneic transplantation settings
por: Masuda, Kyoko, et al.
Publicado: (2021) -
Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
por: Cichocki, Frank, et al.
Publicado: (2023)